Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
David Young currently holds 19,198 shares of Processa Pharmaceuticals, Inc. (PCSA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, David Young has been a net seller of PCSA stock. They have purchased $269.1K and sold $15.4M worth of shares.
David Young's most recent insider trade was on Jun 15, 2026, when they purchased 2,067 shares at $2.22 per share.
David Young serves as Executive at Processa Pharmaceuticals, Inc. (PCSA). They have executed 85 insider transactions totaling $15.7M over their tenure at the company.
David Young holds the position of Executive at Processa Pharmaceuticals, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 18 years and currently hold a stake valued at $0.
David Young has shown a selling trading pattern, with $269.1K in total purchases and $15.4M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by David Young was on Feb 24, 2014, when they sold $1.4M worth of QCOR shares. This transaction involved 17,127 shares at $79.46 per share.
David Young currently owns 19,198 shares of Processa Pharmaceuticals, Inc. (PCSA), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of David Young's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. David Young has 85 Form 4 filings on record as an insider at Processa Pharmaceuticals, Inc..
Set alerts for David Young and 40,000+ other insiders.